{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:54:27Z","timestamp":1789095267253,"version":"build-2803163510"},"reference-count":45,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Histopathology"],"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>\n                      Eosinophilic solid and cystic renal cell carcinoma (ESC\u2010RCC) and\n                      <jats:italic>TFEB<\/jats:italic>\n                      \u2010amplified renal cell carcinoma (\n                      <jats:italic>TFEB<\/jats:italic>\n                      \u2010amplified RCC, a subset of\n                      <jats:italic>TFEB\u2010<\/jats:italic>\n                      altered RCC) are rare eosinophilic renal cell tumours that can be difficult to distinguish on the basis of morphology and immunohistochemistry alone. In this study, we compared the clinicopathological and molecular features of these entities to identify distinguishing characteristics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>\n                      Nine cases of ESC\u2010RCC and six cases of\n                      <jats:italic>TFEB<\/jats:italic>\n                      \u2010amplified RCC from our institutional archives were evaluated for clinical, morphological, immunohistochemical and molecular features. Despite morphological overlap, each entity exhibited somewhat distinctive features. ESC\u2010RCC frequently exhibited solid and cystic architecture with tightly packed tubules, flocculent to coarsely granular cytoplasm with basophilic stippling and prominent admixed macrophages. In comparison,\n                      <jats:italic>TFEB<\/jats:italic>\n                      \u2010amplified RCC more frequently demonstrated solid growth of pseudopapillae and loose tubules, dense eosinophilic granular cytoplasm without basophilic stippling, focally apical nuclei and extracellular magenta globules. However, neither morphology nor immunohistochemistry was sufficiently specific to completely distinguish these entities. Ancillary molecular testing identified pathogenic\n                      <jats:italic>TSC1<\/jats:italic>\n                      or\n                      <jats:italic>TSC2<\/jats:italic>\n                      gene variants in ESC\u2010RCC and\n                      <jats:italic>TFEB<\/jats:italic>\n                      gene locus amplification in\n                      <jats:italic>TFEB<\/jats:italic>\n                      \u2010amplified RCC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Although ESC\u2010RCC and\n                      <jats:italic>TFEB<\/jats:italic>\n                      \u2010RCC share overlapping morphological and immunohistochemical features, each demonstrates somewhat characteristic histological findings. Definitive distinction requires molecular testing to identify the underlying molecular alterations. As molecular testing assumes an increasingly important role in RCC diagnosis and classification, recognition of these rare entities and their overlapping and distinguishing features is essential for appropriate testing and accurate diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/his.70261","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:24:37Z","timestamp":1786609477000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinicopathological and molecular comparison of eosinophilic solid and cystic renal cell carcinoma and\n                    <scp>\n                      <i>TFEB<\/i>\n                    <\/scp>\n                    \u2010amplified renal cell carcinoma: a comprehensive study\u00a0of 15 cases"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2350-6261","authenticated-orcid":false,"given":"Hayley","family":"Zullow","sequence":"first","affiliation":[{"name":"Department of Pathology The University of Chicago  Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5869-3175","authenticated-orcid":false,"given":"Melissa Y.","family":"Tjota","sequence":"additional","affiliation":[{"name":"Department of Pathology The University of Chicago  Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1793-2732","authenticated-orcid":false,"given":"Jung Woo","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Pathology The University of Chicago  Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0455-9413","authenticated-orcid":false,"given":"Tatjana","family":"Antic","sequence":"additional","affiliation":[{"name":"Department of Pathology The University of Chicago  Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"e_1_2_10_2_1","first-page":"23","article-title":"WHO 2022 classification of kidney tumors: What is relevant? An update and future novelties for the pathologist","volume":"115","author":"Cali\u00f2 A","year":"2022","journal-title":"Pathologica"},{"key":"e_1_2_10_3_1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41585-019-0211-5","article-title":"The cancer genome atlas of renal cell carcinoma: Findings and clinical implications","volume":"16","author":"Linehan WM","year":"2019","journal-title":"Nat. Rev. Urol."},{"key":"e_1_2_10_4_1","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jama.2024.12848","article-title":"Renal Cell Carcinoma: A Review","volume":"332","author":"Rose TL","year":"2024","journal-title":"JAMA"},{"key":"e_1_2_10_5_1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 World Health Organization classification of Tumours of the urinary system and male genital organs\u2010part a: Renal, penile, and testicular Tumours","volume":"82","author":"Moch H","year":"2022","journal-title":"Eur. Urol."},{"key":"e_1_2_10_6_1","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.5858\/arpa.2016-0218-RA","article-title":"Morphologic, molecular, and taxonomic evolution of renal cell carcinoma: A conceptual perspective with emphasis on updates to the 2016 World Health Organization classification","volume":"140","author":"Udager AM","year":"2016","journal-title":"Arch. Pathol. Lab Med."},{"key":"e_1_2_10_7_1","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41379-021-00779-w","article-title":"New developments in existing WHO entities and evolving molecular concepts: The genitourinary pathology society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov K","year":"2021","journal-title":"Mod. Pathol."},{"key":"e_1_2_10_8_1","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.hoc.2023.04.014","article-title":"The role of the pathologist in renal cell carcinoma management","volume":"37","author":"Matar S","year":"2023","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"e_1_2_10_9_1","doi-asserted-by":"crossref","DOI":"10.3390\/curroncol32060359","article-title":"Molecular genetics of renal cell carcinoma: A narrative review focused on clinical relevance","volume":"32","author":"Millan B","year":"2025","journal-title":"Curr. Oncol."},{"key":"e_1_2_10_10_1","volume-title":"WHO classification of Tumours: Urinary and male genital Tumours","author":"WHO Classification of Tumours Editorial Board","year":"2022"},{"key":"e_1_2_10_11_1","volume-title":"WHO classification of Tumours: Urinary and male genital Tumours","author":"WHO Classification of Tumours Editorial Board","year":"2022"},{"key":"e_1_2_10_12_1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15164043","article-title":"Recent advances in renal tumors with TSC\/mTOR pathway abnormalities in patients with tuberous sclerosis complex and in the sporadic setting","volume":"15","author":"Kapur P","year":"2023","journal-title":"Cancer"},{"key":"e_1_2_10_13_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-44229-4","article-title":"TFEB drives mTORC1 hyperactivation and kidney disease in tuberous sclerosis complex","volume":"15","author":"Alesi N","year":"2024","journal-title":"Nat. Commun."},{"key":"e_1_2_10_14_1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/PAS.0000000000001067","article-title":"Are sporadic eosinophilic solid and cystic renal cell carcinomas characterized by somatic tuberous sclerosis gene mutations?","volume":"42","author":"Parilla M","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"e_1_2_10_15_1","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/PAS.0000000000001457","article-title":"Eosinophilic renal cell tumors with a TSC and MTOR gene mutations are morphologically and immunohistochemically heterogenous: Clinicopathologic and molecular study","volume":"44","author":"Tjota M","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"e_1_2_10_16_1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/his.14663","article-title":"Eosinophilic solid and cystic renal cell carcinoma and renal cell carcinomas with TFEB alterations: A comparative study","volume":"81","author":"Lobo J","year":"2022","journal-title":"Histopathology"},{"key":"e_1_2_10_17_1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/his.15560","article-title":"MiT family translocation carcinomas of the kidney and related entities","volume":"88","author":"Argani P","year":"2026","journal-title":"Histopathology"},{"key":"e_1_2_10_18_1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/his.70001","article-title":"Recent developments in eosinophilic renal neoplasms: what's new, true and important?","volume":"88","author":"Trpkov K","year":"2026","journal-title":"Histopathology"},{"key":"e_1_2_10_19_1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/his.70008","article-title":"Renal cell tumours with papillary architecture: Evolving concepts, classification and new emerging entities","volume":"88","author":"Alruwaii ZI","year":"2026","journal-title":"Histopathology"},{"key":"e_1_2_10_20_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2026.106141","article-title":"Morphology spectrum and molecular landscape in eosinophilic solid and cystic renal cell carcinoma","volume":"174","author":"Wang Q","year":"2026","journal-title":"Hum. Pathol."},{"key":"e_1_2_10_21_1","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/PAS.0000000000001111","article-title":"Eosinophilic solid and cystic (ESC) renal cell Carcinomas Harbor TSC mutations: Molecular analysis supports an expanding clinicopathologic Spectrum","volume":"42","author":"Palsgrove DN","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"e_1_2_10_22_1","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1097\/PAS.0000000000000720","article-title":"TFEB\u2010amplified renal cell carcinomas: An aggressive molecular subset demonstrating variable melanocytic marker expression and morphologic heterogeneity","volume":"40","author":"Argani P","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"e_1_2_10_23_1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jmoldx.2016.07.012","article-title":"Clinical validation of a next\u2010generation sequencing genomic oncology panel via cross\u2010platform benchmarking against established amplicon sequencing assays","volume":"19","author":"Kadri S","year":"2017","journal-title":"J. Mol. Diagn."},{"key":"e_1_2_10_24_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: Genome\u2010wide copy number detection and visualization from targeted DNA sequencing","volume":"12","author":"Talevich E","year":"2016","journal-title":"PLoS Comput. Biol."},{"key":"e_1_2_10_25_1","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao J","year":"2013","journal-title":"Sci. Signal."},{"key":"e_1_2_10_26_1","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/PAS.0000000000001307","article-title":"TFEB expression profiling in renal cell carcinomas: Clinicopathologic correlations","volume":"43","author":"Gupta S","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"e_1_2_10_27_1","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0000000000000838","article-title":"Eosinophilic solid and cystic renal cell carcinoma (ESC RCC): Further morphologic and molecular characterization of ESC RCC as a distinct entity","volume":"41","author":"Trpkov K","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"e_1_2_10_28_1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115982","article-title":"Eosinophilic solid and cystic renal cell carcinoma\u2010a systematic review and meta\u2010analysis","volume":"25","author":"Loghin A","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"e_1_2_10_29_1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.clgc.2023.11.008","article-title":"Prognosis and clinicopathological characters of adult TFEB\u2010altered renal cell carcinoma: A single center experience of 18 cases","volume":"22","author":"Wu J","year":"2024","journal-title":"Clin. Genitourin. Cancer"},{"key":"e_1_2_10_30_1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/PAS.0000000000000508","article-title":"Eosinophilic, solid, and cystic renal cell carcinoma: Clinicopathologic study of 16 unique, sporadic neoplasms occurring in women","volume":"40","author":"Trpkov K","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"e_1_2_10_31_1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/his.14683","article-title":"Comprehensive study of nine novel cases of TFEB\u2010amplified renal cell carcinoma: An aggressive tumour with frequent PDL1 expression","volume":"81","author":"Kammerer\u2010Jacquet SF","year":"2022","journal-title":"Histopathology"},{"key":"e_1_2_10_32_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105797","article-title":"Evaluation of 3,606 renal cell tumors for TFE3 rearrangements and TFEB alterations via fluorescence in situ hybridization, next generation sequencing, and GPNMB immunohistochemistry","volume":"159","author":"Whaley RD","year":"2025","journal-title":"Hum. Pathol."},{"key":"e_1_2_10_33_1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/PAS.0000000000002413","article-title":"Clinically sporadic folliculin \u2010mutated renal epithelial neoplasms represent a mixture of True somatic folliculin \u2010mutated and occult Birt\u2010hogg\u2010Dub\u00e9 syndrome\u2010associated cases: Morphologic and molecular overlap with TSC\/MTOR \u2010mutated eosinophilic renal neoplasms and MiT family translocation renal cell carcinoma","volume":"49","author":"Argani P","year":"2025","journal-title":"Am. J. Surg. Pathol."},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428\u2010025\u201004363\u20104"},{"key":"e_1_2_10_35_1","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.1158\/1078-0432.CCR-19-0733","article-title":"TFEB mediates immune evasion and resistance to mTOR inhibition of renal cell carcinoma via induction of PD\u2010L1","volume":"25","author":"Zhang C","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_10_36_1","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.7150\/jca.35738","article-title":"Determination of the expression of PD\u2010L1 in the morphologic Spectrum of renal cell carcinoma","volume":"11","author":"Walter B","year":"2020","journal-title":"J. Cancer"},{"key":"e_1_2_10_37_1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/PAS.0000000000002458","article-title":"Clinicopathologic and molecular study of TFEB \u2010altered renal cell carcinomas: Tumors with frequent PDL1 expression","volume":"50","author":"Zhang M","year":"2026","journal-title":"Am. J. Surg. Pathol."},{"key":"e_1_2_10_38_1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/PAI.0000000000000458","article-title":"Fading with time of PD\u2010L1 immunoreactivity in non\u2010small cells lung cancer tissues: A methodological study","volume":"26","author":"Giunchi F","year":"2018","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"e_1_2_10_39_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100159","article-title":"Tissue age affects antigenicity and scoring for the 22C3 immunohistochemistry companion diagnostic test","volume":"36","author":"Fernandez AI","year":"2023","journal-title":"Mod. Pathol."},{"key":"e_1_2_10_40_1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/10668969231185077","article-title":"A TFEB\u2010amplified renal cell carcinoma with Long\u2010term, complete immunotherapy response: Retrospective support for the value of molecular classification","volume":"32","author":"Smith SC","year":"2024","journal-title":"Int. J. Surg. Pathol."},{"key":"e_1_2_10_41_1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41379-021-00971-y","article-title":"Renal cell carcinoma associated with tuberous sclerosis complex (TSC)\/mammalian target of rapamycin (MTOR) genetic alterations","volume":"35","author":"Argani P","year":"2022","journal-title":"Mod. Pathol."},{"key":"e_1_2_10_42_1","first-page":"359","article-title":"The Spectrum of renal \u201cTFEopathies\u201d: Flipping the mTOR switch in renal tumorigenesis","volume":"39","author":"Alesi N","year":"2024","journal-title":"Physiology (Bethesda)"},{"key":"e_1_2_10_43_1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/10668969241260236","article-title":"Genotype phenotype correlation of renal tumors in the cancer genome atlas database","volume":"33","author":"Albertson D","year":"2025","journal-title":"Int. J. Surg. Pathol."},{"key":"e_1_2_10_44_1","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-12-184","article-title":"Accurate and exact CNV identification from targeted high\u2010throughput sequence data","volume":"12","author":"Nord AS","year":"2011","journal-title":"BMC Genomics"},{"key":"e_1_2_10_45_1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ygeno.2013.04.006","article-title":"Diagnosis of copy number variation by Illumina next generation sequencing is comparable in performance to oligonucleotide array comparative genomic hybridisation","volume":"102","author":"Hayes JL","year":"2013","journal-title":"Genomics"},{"key":"e_1_2_10_46_1","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/CM9.0000000000004001","article-title":"Targeted next\u2010generation sequencing for copy number variation detection: Recent progress in clinical oncology","volume":"139","author":"Du Z","year":"2026","journal-title":"Chin. Med. J."}],"container-title":["Histopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/his.70261","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/his.70261","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/his.70261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:24:43Z","timestamp":1786609483000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/his.70261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":45,"alternative-id":["10.1111\/his.70261"],"URL":"https:\/\/doi.org\/10.1111\/his.70261","archive":["Portico"],"relation":{},"ISSN":["0309-0167","1365-2559"],"issn-type":[{"value":"0309-0167","type":"print"},{"value":"1365-2559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"2026-01-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"his.70261"}}